发明名称 |
GALECTIN-1 SECRETED FROM MESENCHYMAL STEM CELLS MODULATES EXTRACELLULAR α-SYNUCLEIN BY INHIBITING TRANSMISSION VIA CLATHRIN-MEDIATED ENDOCYTOSIS |
摘要 |
The present invention relates to a method for treating Parkinson′s disease associated with aggregation of alpha-synuclein. More specifically, regulation of N-methyl-D-aspartate (NMDA) receptors on a cell surface using galectin-1 derived from mesenchymal stem cells brings inhibition of clathrin-mediated endocytosis (CME) of extracellular alpha-synuclein, thereby blocking formation of alpha-synuclein aggregates. Thus, it is possible to treat or prevent disease such as Parkinson′s disease induced by alpha-synuclein aggregation. |
申请公布号 |
KR20160074263(A) |
申请公布日期 |
2016.06.28 |
申请号 |
KR20140183367 |
申请日期 |
2014.12.18 |
申请人 |
INDUSTRY-ACADEMIC COOPERATION FOUNDATION, YONSEI UNIVERSITY |
发明人 |
LEE, PHIL HYU;KIM, HA NA;SHIN, JIN YOUNG |
分类号 |
A61K38/17;A61K38/16;A61P25/16 |
主分类号 |
A61K38/17 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|